February 7th, 2012
Posted on 05. Mar, 2010 by PublicWire in Medical
3/5 (IBPM.OB) iBio Appoints Chief Scientific Officer
(PublicWire) — Biopharmaceutical company iBio Inc. (OTCBB: IBPM) reported on Thursday the appointment of Vidadi Yusibov, Ph.D. as chief scientific officer.
Dr. Yusibov is executive director of the Fraunhofer USA Center for Molecular Biotechnology (CMB) in Newark, Delaware, a position he will continue to hold.
He is also a senior research fellow at the Delaware Biotechnology Institute.
Before joining CMB, Dr. Yusibov served as assistant professor in the Department of Microbiology and Immunology at Thomas Jefferson University in Philadelphia.